Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1

Journal of Investigative Dermatology

Volumn 113, Issue 2, 1999, Pages 162-169

  Madsen, Peder ^a   Anant, Shrikant ^b,f   Rasmussen, Hanne H ^a   Gromov, Pavel ^d   Vorum, Henrik ^a   Dumanski, Jan P ^c   Tommerup, Niels ^d   Collins, John E ^e   Wright, Charmain L ^e   Dunham, Ian ^e   MacGinnitie, Andrew J ^b,f   Davidson, Nicholas O ^b,f   Celis, Julio E ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF CHICAGO   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CDNA cloning; MRNA editing

Indexed keywords

APOLIPOPROTEIN B; COMPLEMENTARY DNA; MESSENGER RNA;

AMINO ACID SEQUENCE; ARTICLE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PSORIASIS; SKIN DISEASE;

EID: 0033511807     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00682.x     Document Type: Article

References (57)

1. Anant S, MacGinnitie AJ, Davidson NO: Apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J Biol Chem 270:14762-14767, 1995
2. Anant S, Martin SA, Yu H, MacGinnitie AJ, Devaney E, Davidson NO: A cytidine deaminase expressed in the post-infective L3 stage of the filarial nematode, Brugia pahangi, has a novel RNA-binding activity. Mol Biochem Parasitol 88:105-114, 1997
3. Ashkenas J: Gene regulation by mRNA editing. Am J Hum Genet 60:278-283, 1997
4. Barker JN: The immunopathology of psoriasis. Baillières Clin Rheumatol 8:429-438, 1994
5. Barker JN: Adhesion molecules in cutaneous inflammation. CIBA Found Symp 189:91-101; 1995
6. Betts L, Xiang S, Short SA, Wolfenden R, Carter CWJ: Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex. J Mol Biol 235:635-656, 1994
7. Bhattacharya S, Navaratnam N, Morrison JR, Scott J, Taylor WR: Cytosine nucleoside/nucleotide deaminases and apolipoprotein B mRNA editing. Trends Biochem Sci 19:105-106, 1994
8. 14C]-labeled amino acids. Clin Chem 28:766-781, 1982
9. Calkhoven CF, Bouwman PR, Snippe L, Ab G: Translation start site multiplicity of the CCAAT/enhancer binding protein alpha mRNA is dictated by a small 5′ open reading frame. Nucleic Acids Res 22:5540-5547, 1994
10. Cappione AJ, French BL, Skuse GR: A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors. Am J Hum Genet 60:305-312, 1997
11. Celis JE, Basse B, Lauridsen JB. Determination of antibody specificity by Western blotting and immunoprecipitation. In: Celis JE (ed.). Cell Biology. A Laboratory Handbook, Vol. 2. San Diego: Academic Press, 1994a: pp 305-321
12. Celis JE, Ratz G, Basse B, Lauridsen JB, Celis A. high-resolution two dimensional gel electrophoresis of proteins: isoelectric focusing and nonequilibrium pH gradient electrophoresis (NEPHGE). In: Celis JE (ed.). Cell Biology: a Laboratory Handbook, Vol. 3. San Diego: Academic Press, 1994b: pp 222-230
13. Celis JE, Gromov P, Ostergaard M, et al: Human 2-D PAGE databases for protcome analysis in health and disease: http://biobase.dk/cgi-bin/celis. FEBS Lett 398:129-134, 1996
14. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979
15. Christensen JH, Hansen PK, Lillelund O, Thøgersen HC: Sequence-specific binding of the N-terminal three-finger fragment of Xenopus transcription factor IIIA to the internal control region of a 5S RNA gene. FEBS Lett 281:181-184, 1991
16. Christophers E: Psoriasis: mechanisms and entry points for possible therapeutic interventions. Australas J Dermatol 37 (Suppl. 1):S4-S6, 1996
17. Collins JE, Cole CG, Smink LJ, et al: A high-density YAC contig map of human chromosome 22. Nature 377:367-379, 1995
18. Descombes P, Schibler U: A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569-579, 1991
19. Elder JT, Tavakkol A, Klein SB, Zeigler ME, Wicha M, Voorhees JJ: Protooncogene expression in normal and psoriatic skin. J Invest Dermatol 94:19-25, 1990
20. Felsenstein J: Phylogenies from molecular sequences: inference and reliability. Annu Rev Genet 22:521-565, 1988
21. Fisher GJ, Talwar HS, Baldassare JJ, Henderson PA, Voorhees JJ: Increased phospholipasc C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis. J Invest Dermatol 95:428-435, 1990
22. Fisher GJ, Tavakkol A, Leach K, et al: Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin: reduced expression of protein kinase C-beta II in psoriasis. J Invest Dermatol 101:553-559, 1993
23. Geballe AP, Morris DR: Initiation codons within 5′-leaders of mRNAs as regulators of translation. Trends Biochem Sci 19:159-164, 1994
24. Giannoni F, Bonen DK, Funahashi T, Hadjiagapiou C, Burant CF, Davidson NO: Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J Biol Chem 269:5932-5936, 1994
25. Gubler U, Huffman BJ: A simple and very efficient method for generating cDNA libraries. Gene 25:263-269, 1983
26. Gupta AK, Fisher GJ, Elder JT, Nickoloff BJ, Voorhees JJ: Sphingosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity, and activation of protein kinase C in mouse skin. J Invest Dermatol 91:486-491, 1988
27. Hegemann L, van Bonnekoh B, Rooijen LA, Mahrle G: Anti-proliferative effects of protein kinase C inhibitors in human keratinocytes. J Dermatol Sci 4:18-25, 1992a
28. Hegemann L, van Fruchtmann R, Rooijen LA, Muller-Peddinghaus R, Mahrle G: The antipsoriatic drug, anthralin, inhibits protein kinase C - implications forits mechanism of action. Arch Dermatol Res 284:179-183, 1992b
29. Hochuli E, Dobeli H, Schacher A: New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues. J Chromatogr 411:177-184, 1987
30. Honoré B, Madsen P: The tetramethylammonium chloride (TMAC) method for screening cDNA libraries with highly degenerate oligonucleotide probes obtained by reverse translation of amino acid sequences. Methods Mol Biol 69:139-146, 1997
31. Horn F, Marks F, Fisher GJ, Marcelo CL, Voorhees JJ: Decreased protein kinase C activity in psoriatic venus normal epidermis. J Invest Dermatol 88:220-222, 1987
32. Kozak M: The scanning model for translation: an update. J Cell Biol 108:229-241, 1989
33. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
34. MacGinnitie AJ, Anant S, Davidson NO: Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. J Biol Chem 270:14768-14775, 1995
35. Madscn P, Rasmussen HH, Leffers H, et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein 'psoriasin' that is highly up-regulated in psoriatic skin. J Invest Dermatol 97:701-712, 1991
36. Madsen P. Rasmussen HH, Leffers H, Honoré B, Celis JE: Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J Invest Dermatol 99:299-305, 1992
37. Madsen P, Gromov P, Celis JE: Expression of cDNA clones by coupled in vitro transcription/translation and transfection into COS-1 cells: protein mapping in two-dimensional gels. Electrophoresis 16:2258-2261, 1995
38. Navaratnam N, Bhattacharya S, Fujino T, Patel D, Jarmuz AL, Scott J: Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell 81:187-195, 1995
39. Nishizuka Y: Intrazellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614, 1992
40. Norris DA, Travers JB, Leung DY: Lymphocyte activation in the pathogenesis of psoriasis. J Invest Dermatol 109:1-4, 1997
41. O'Farrell PH: High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007-4021, 1975
42. Peltonen J, Karvonen SL, Yla-Outinen H, Hirvonen O, Karvonen J: Lesional psoriatic epidermis displays reduced neurofibromin immunoreactivity. J Invest Dermatol 105:664-667, 1995
43. Rasmussen HH, Celis JE: Evidence for an altered protein kinase C (PKC) signaling pathway in psoriasis. J Invest Dermatol 101:560-566, 1993
44. Reynolds K, Zimmer AM, Zimmer A: Regulation of RAR beta 2 mRNA expression: evidence for an inhibitory peptide encoded in the 5′-untranslated region. J Cell Biol 134:827-835, 1996
45. Sanger F, Nicklen S, Coulson AR; DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467, 1977
46. Sharma PM, Bowman M, Madden SL, Rauscher FJ, Sukumar S: RNA editing in the Wilms' tumor susceptibility gene, WT1. Genes Dev 8:720-731, 1994
47. Skuse GR, Cappione AJ, Sowden M, Metheny LJ, Smith HC: The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing. Nucleic Acids Res 24:478-485, 1996
48. Teng B, Burant CF, Davidson NO: Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260:1816-1819, 1993
49. Tommerup N, Vissing H: Isolation and fine mapping of 16 novel human zinc finger-encoding cDNAs identify putative candidate genes for developmental and malignant disorders. Genomics 27:259-264, 1995
50. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979
51. Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L: Psoriasis: a T-cell mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 16:145-149, 1995
52. Rasmnssen HH, Van Damme J, Bauw M, Puype M, Gesser B, Celis JE, Vanderkerckhove J. Protein-electroblotting and microscquencing in establishing integrated human protein databases. In: Jörnvall H, Höög JO, Gustavsson AM (eds). Methods in Protein Sequence Analysis, Basel: Birkhäuser, 1991:pp 103-141
53. Vanderkerckhove J, Rasmussen HH. Internal amino acid sequencing of proteins recovered from one- or two dimensional gels. In: Celis JE (ed.) Cell Biobgy. A Laboratory Handbook, Vol. 3, San Diego: Academic Press, 1994:pp 359-368
54. Venneker GT, Das PK, van Meinardi MM, Marie J, Veen HA, Bos JD, Asghar SS: Glycosylphosphatidylinositol (GPI) -anchored membrane proteins are constitutively down-regulated in psoriatic skin. J Pathol 172:189-197, 1994
55. Wiedow O, Young JA, Davison MD, Christophers E: Antileukoprotease in psoriatic scales. J Invat Dermatol 101:305-309, 1993
56. Wright NA, Camplejohn RS: Psoriasis: Cell proliferation. Edinburgh: Churchill Livingstone, 1985
57. Xie YG, Han FY, Peyrard M, et al: Cloning of a novel, anonymous gene from a megabase-range YAC and cosmid contig in the neurofibromatosis type 2/meningioma region on human chromosome 22q12. Hum Mol Genet 2:1361-1368, 1993